Literature DB >> 24131711

Characterization of the envelope glycoprotein of a novel filovirus, lloviu virus.

Junki Maruyama1, Hiroko Miyamoto, Masahiro Kajihara, Hirohito Ogawa, Ken Maeda, Yoshihiro Sakoda, Reiko Yoshida, Ayato Takada.   

Abstract

Lloviu virus (LLOV), a novel filovirus detected in bats, is phylogenetically distinct from viruses in the genera Ebolavirus and Marburgvirus in the family Filoviridae. While filoviruses are known to cause severe hemorrhagic fever in humans and/or nonhuman primates, LLOV is biologically uncharacterized, since infectious LLOV has never been isolated. To examine the properties of LLOV, we characterized its envelope glycoprotein (GP), which likely plays a key role in viral tropism and pathogenicity. We first found that LLOV GP principally has the same primary structure as the other filovirus GPs. Similar to the other filoviruses, virus-like particles (VLPs) produced by transient expression of LLOV GP, matrix protein, and nucleoprotein in 293T cells had densely arrayed GP spikes on a filamentous particle. Mouse antiserum to LLOV VLP was barely cross-reactive to viruses of the other genera, indicating that LLOV is serologically distinct from the other known filoviruses. For functional study of LLOV GP, we utilized a vesicular stomatitis virus (VSV) pseudotype system and found that LLOV GP requires low endosomal pH and cathepsin L, and that human C-type lectins act as attachment factors for LLOV entry into cells. Interestingly, LLOV GP-pseudotyped VSV infected particular bat cell lines more efficiently than viruses bearing other filovirus GPs. These results suggest that LLOV GP mediates cellular entry in a manner similar to that of the other filoviruses while showing preferential tropism for some bat cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24131711      PMCID: PMC3911722          DOI: 10.1128/JVI.02265-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  Proteolytic processing of Marburg virus glycoprotein.

Authors:  V E Volchkov; V A Volchkova; U Ströher; S Becker; O Dolnik; M Cieplik; W Garten; H D Klenk; H Feldmann
Journal:  Virology       Date:  2000-03-01       Impact factor: 3.616

Review 2.  Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications.

Authors:  Ayato Takada; Yoshihiro Kawaoka
Journal:  Rev Med Virol       Date:  2003 Nov-Dec       Impact factor: 6.989

3.  C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans.

Authors:  Carmen P Alvarez; Fátima Lasala; Jaime Carrillo; Oscar Muñiz; Angel L Corbí; Rafael Delgado
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

4.  The macrophage C-type lectin specific for galactose/N-acetylgalactosamine is an endocytic receptor expressed on monocyte-derived immature dendritic cells.

Authors:  Nobuaki Higashi; Kouki Fujioka; Kaori Denda-Nagai; Shin-Ichi Hashimoto; Shigenori Nagai; Taku Sato; Yuko Fujita; Akiko Morikawa; Makoto Tsuiji; Megumi Miyata-Takeuchi; Yoshihiko Sano; Noriko Suzuki; Kazuo Yamamoto; Kouji Matsushima; Tatsuro Irimura
Journal:  J Biol Chem       Date:  2002-03-27       Impact factor: 5.157

5.  Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR.

Authors:  H Feinberg; D A Mitchell; K Drickamer; W I Weis
Journal:  Science       Date:  2001-12-07       Impact factor: 47.728

6.  Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP.

Authors:  Takeshi Noda; Hiroshi Sagara; Emiko Suzuki; Ayato Takada; Hiroshi Kida; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

7.  Infectivity-enhancing antibodies to Ebola virus glycoprotein.

Authors:  A Takada; S Watanabe; K Okazaki; H Kida; Y Kawaoka
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

8.  Quantitative expression and virus transmission analysis of DC-SIGN on monocyte-derived dendritic cells.

Authors:  Frédéric Baribaud; Stefan Pöhlmann; George Leslie; Frank Mortari; Robert W Doms
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

9.  Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR.

Authors:  George Lin; Graham Simmons; Stefan Pöhlmann; Frédéric Baribaud; Houping Ni; George J Leslie; Beth S Haggarty; Paul Bates; Drew Weissman; James A Hoxie; Robert W Doms
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

10.  DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells.

Authors:  Graham Simmons; Jacqueline D Reeves; Case C Grogan; Luk H Vandenberghe; Frédéric Baribaud; J Charles Whitbeck; Emily Burke; Michael J Buchmeier; Elizabeth J Soilleux; James L Riley; Robert W Doms; Paul Bates; Stefan Pöhlmann
Journal:  Virology       Date:  2003-01-05       Impact factor: 3.616

View more
  41 in total

1.  Cell entry by a novel European filovirus requires host endosomal cysteine proteases and Niemann-Pick C1.

Authors:  Melinda Ng; Esther Ndungo; Rohit K Jangra; Yingyun Cai; Elena Postnikova; Sheli R Radoshitzky; John M Dye; Eva Ramírez de Arellano; Ana Negredo; Gustavo Palacios; Jens H Kuhn; Kartik Chandran
Journal:  Virology       Date:  2014-10-11       Impact factor: 3.616

2.  Global Substance Registration System: consistent scientific descriptions for substances related to health.

Authors:  Tyler Peryea; Noel Southall; Mitch Miller; Daniel Katzel; Niko Anderson; Jorge Neyra; Sarah Stemann; Ðắc-Trung Nguyễn; Dammika Amugoda; Archana Newatia; Ramez Ghazzaoui; Elaine Johanson; Herman Diederik; Larry Callahan; Frank Switzer
Journal:  Nucleic Acids Res       Date:  2021-01-08       Impact factor: 16.971

3.  Interaction between TIM-1 and NPC1 Is Important for Cellular Entry of Ebola Virus.

Authors:  Makoto Kuroda; Daisuke Fujikura; Asuka Nanbo; Andrea Marzi; Osamu Noyori; Masahiro Kajihara; Junki Maruyama; Keita Matsuno; Hiroko Miyamoto; Reiko Yoshida; Heinz Feldmann; Ayato Takada
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

4.  The Tetherin Antagonism of the Ebola Virus Glycoprotein Requires an Intact Receptor-Binding Domain and Can Be Blocked by GP1-Specific Antibodies.

Authors:  Constantin Brinkmann; Inga Nehlmeier; Kerstin Walendy-Gnirß; Julia Nehls; Mariana González Hernández; Markus Hoffmann; Xiangguo Qiu; Ayato Takada; Michael Schindler; Stefan Pöhlmann
Journal:  J Virol       Date:  2016-11-28       Impact factor: 5.103

Review 5.  The multiple roles of sGP in Ebola pathogenesis.

Authors:  Marc-Antoine de La Vega; Gary Wong; Gary P Kobinger; Xiangguo Qiu
Journal:  Viral Immunol       Date:  2015-02       Impact factor: 2.257

Review 6.  Neglected filoviruses.

Authors:  Robin Burk; Laura Bollinger; Joshua C Johnson; Jiro Wada; Sheli R Radoshitzky; Gustavo Palacios; Sina Bavari; Peter B Jahrling; Jens H Kuhn
Journal:  FEMS Microbiol Rev       Date:  2016-06-05       Impact factor: 16.408

7.  Chimeric Filoviruses for Identification and Characterization of Monoclonal Antibodies.

Authors:  Philipp A Ilinykh; Xiaoli Shen; Andrew I Flyak; Natalia Kuzmina; Thomas G Ksiazek; James E Crowe; Alexander Bukreyev
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

Review 8.  Distinct Genome Replication and Transcription Strategies within the Growing Filovirus Family.

Authors:  Adam J Hume; Elke Mühlberger
Journal:  J Mol Biol       Date:  2019-06-29       Impact factor: 5.469

9.  Structural Insights into the Interaction of Filovirus Glycoproteins with the Endosomal Receptor Niemann-Pick C1: A Computational Study.

Authors:  Manabu Igarashi; Takatsugu Hirokawa; Yoshihiro Takadate; Ayato Takada
Journal:  Viruses       Date:  2021-05-14       Impact factor: 5.048

Review 10.  Role of Lipid Transfer Proteins (LTPs) in the Viral Life Cycle.

Authors:  Kiran Avula; Bharati Singh; Preethy V Kumar; Gulam H Syed
Journal:  Front Microbiol       Date:  2021-06-23       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.